202 related articles for article (PubMed ID: 2819791)
1. Supersensitivity of striatal D2 dopamine receptors mediating inhibition of adenylate cyclase and stimulation of guanosine triphosphatase following chronic administration of haloperidol in mice.
Olianas MC; Onali P
Neurosci Lett; 1987 Aug; 78(3):349-54. PubMed ID: 2819791
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
Onali P; Olianas MC
Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
[TBL] [Abstract][Full Text] [Related]
3. Modulation by GTP of basal and agonist-stimulated striatal adenylate cyclase activity following chronic blockade of D1 and D2 dopamine receptors: involvement of G proteins in the development of receptor supersensitivity.
Schettini G; Ventra C; Florio T; Grimaldi M; Meucci O; Marino A
J Neurochem; 1992 Nov; 59(5):1667-74. PubMed ID: 1402912
[TBL] [Abstract][Full Text] [Related]
4. Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum.
Olianas MC; Onali P
J Neurochem; 1987 May; 48(5):1443-7. PubMed ID: 2951497
[TBL] [Abstract][Full Text] [Related]
5. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
O'Shaughnessy CT; Headley PM
Eur J Pharmacol; 1986 Jun; 125(1):79-83. PubMed ID: 3015643
[TBL] [Abstract][Full Text] [Related]
6. Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function.
Broaddus WC; Bennett JP
Brain Res Dev Brain Res; 1990 Mar; 52(1-2):273-7. PubMed ID: 2110042
[TBL] [Abstract][Full Text] [Related]
7. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic electroconvulsive shock on D1 and D2 dopamine receptor-mediated activity of adenylate cyclase in homogenates of striatum and limbic forebrain of rat.
Newman ME; Lerer B
Neuropharmacology; 1989 Aug; 28(8):787-90. PubMed ID: 2674765
[TBL] [Abstract][Full Text] [Related]
9. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
10. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
[TBL] [Abstract][Full Text] [Related]
12. D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo.
Saller CF; Salama AI
J Pharmacol Exp Ther; 1986 Mar; 236(3):714-20. PubMed ID: 3005552
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
14. Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol.
Memo M; Pizzi M; Missale C; Carruba MO; Spano PF
Neuropharmacology; 1987 May; 26(5):477-80. PubMed ID: 2955241
[TBL] [Abstract][Full Text] [Related]
15. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats.
Onali P; Olianas MC; Gessa GL
Eur J Pharmacol; 1984 Mar; 99(1):127-8. PubMed ID: 6233165
[No Abstract] [Full Text] [Related]
16. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
[TBL] [Abstract][Full Text] [Related]
17. Chronic desipramine treatment influences D1 stimulation and D2 inhibition (dual control) of adenylate cyclase by dopamine in rat striatum.
Okada F; Horikawa T; Tokumitsu Y; Nomura Y
Neurochem Int; 1994 Jan; 24(1):23-7. PubMed ID: 8130732
[TBL] [Abstract][Full Text] [Related]
18. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
Battaglia G; Norman AB; Hess EJ; Creese I
J Neurochem; 1986 Apr; 46(4):1180-5. PubMed ID: 3005508
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
Brain Res; 1988 Jul; 455(2):390-3. PubMed ID: 2969768
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum.
Meschler JP; Howlett AC
Neuropharmacology; 2001 Jun; 40(7):918-26. PubMed ID: 11378162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
